Jacobin on MSN34m
You’ve Already Paid for Overpriced Weight-Loss Drugs
US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...
Pfizer appoints former J&J executive to lead obesity drug development
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...